DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,883 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $15,808,259 | -1.3% | 63,271 | -1.4% | 0.37% | -1.6% |
| Q1 2024 | $16,017,000 | +13.1% | 64,141 | +4.7% | 0.38% | -1.3% |
| Q4 2023 | $14,167,000 | +97227.6% | 61,240 | +4.4% | 0.38% | -15.1% |
| Q3 2023 | $14,556 | +6.4% | 58,671 | +2.9% | 0.45% | +11.4% |
| Q2 2023 | $13,680 | -1.7% | 57,000 | +3.2% | 0.40% | -8.6% |
| Q1 2023 | $13,918 | -2.0% | 55,221 | +3.2% | 0.44% | -9.4% |
| Q4 2022 | $14,199 | -99.9% | 53,498 | +3.1% | 0.49% | -3.8% |
| Q3 2022 | $13,400,000 | -1.3% | 51,878 | -3.2% | 0.51% | +10.7% |
| Q2 2022 | $13,580,000 | -4.3% | 53,567 | +10.8% | 0.46% | +11.2% |
| Q1 2022 | $14,187,000 | -10.5% | 48,367 | +0.3% | 0.41% | -6.2% |
| Q4 2021 | $15,859,000 | +16.0% | 48,203 | +7.3% | 0.44% | -0.2% |
| Q3 2021 | $13,672,000 | +13.4% | 44,910 | 0.0% | 0.44% | +9.8% |
| Q2 2021 | $12,052,000 | +16.1% | 44,910 | -2.6% | 0.40% | +15.6% |
| Q1 2021 | $10,382,000 | +3.0% | 46,124 | +1.6% | 0.35% | +3.6% |
| Q4 2020 | $10,084,000 | – | 45,394 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
| Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
| Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
| Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
| CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
| Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
| Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
| BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
| Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |